Table 1 Pre and Post vaccination mean of phenotypic markers at various stages in different groups:
| Â | CD4 | CD8 | CD16+56 | CD45RA | CD 45RO |
|---|---|---|---|---|---|
Group IA | |||||
Stage B | 393 ± 137/mm3 | 1374 ± 477/mm3 | 292 ± 194/mm3 | 1237 ± 480/mm3 | 1320 ± 490 mm3 |
Stage D | 526 ± 178/mm3 | 1580 ± 478/mm3 | 269 ± 139/mm3 | 1471 ± 435/mm3 | 1548 ± 502 mm3 |
Stage F | 632 ± 235/mm3 | 1645 ± 408/mm3 | 302 ± 188/mm3 | 1719 ± 590/mm3 | 1727 ± 538 mm3 |
Statistical analysis | B/D p < 0.01 | B/D p < 0.05 | B/D p > 0.05 | B/D p < 0.01 | B/D p < 0.01 |
| Â | B/Fp < 0.01 | B/F p < 0.01 | B/F p > 0.05 | B/F p < 0.01 | B/F p < 0.01 |
| Â | D/Fp < 0.01 | D/F p > 0.05 | D/F p > 0.05 | D/Fp < 0.01 | D/F p < 0.05 |
Group I B | |||||
Stage B | 117 ± 47/mm3 | 1082 ± 828/mm3 | 170 ± 119/mm3 | 760 ± 299/mm3 | 1015 ± 660 mm3 |
Stage D | 169 ± 111/mm3 | 1354 ± 1003/mm3 | 193 ± 124/mm3 | 908 ± 341/mm3 | 1125 ± 780 mm3 |
Stage F | 248 ± 146/mm3 | 1609 ± 949/mm3 | 293 ± 239/mm3 | 1328 ± 662/mm3 | 1461 ± 799 mm3 |
Statistical analysis | B/D p < 0.05 | B/D p > 0.05 | B/D p > 0.05 | B/D p > 0.05 | B/D p > 0.05 |
| Â | B/F p < 0.01 | B/F p < 0.05 | B/F p < 0.05 | B/F p < 0.01 | B/F p < 0.05 |
| Â | D/Fp < 0.01 | D/Fp > 0.05 | D/Fp > 0.05 | D/Fp < 0.05 | D/Fp < 0.01 |
Group II | |||||
Stage B | 743 ± 208/mm3 | 756 ± 325/mm3 | 252 ± 121/mm3 | 1213 ± 467/mm3 | 1041 ± 398 mm3 |
Stage D | 862 ± 263/mm3 | 865 ± 390/mm3 | 364 ± 190/mm3 | 1338 ± 624/mm3 | 1235 ± 303 mm3 |
Stage F | 937 ± 183/mm3 | 954 ± 335/mm3 | 490 ± 304/mm3 | 1592 ± 418/mm3 | 1209 ± 256 mm3 |
Statistical analysis | B/D p > 0.05 | B/D p > 0.05 | B/D p < 0.05 | B/D p > 0.05 | B/D p < 0.01 |
| Â | B/F p < 0.01 | B/F p < 0.01 | B/F p < 0.01 | B/F p < 0.01 | B/F p < 0.05 |
| Â | D/Fp > 0.01 | D/Fp > 0.05 | D/F p < 0.05 | D/Fp < 0.05 | D/Fp > 0.05 |